{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T14:04:33Z","timestamp":1767276273741},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T00:00:00Z","timestamp":1195084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T00:00:00Z","timestamp":1195084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Filaria J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>In Sri Lanka filariasis is endemic in Southern, Western and North Western provinces covering eight districts designated as implementation units in the Programme for the Elimination of Lymphatic Filariasis (PELF). Despite control activities over sixty years including multidose diethylcarbamazine, 6 mg\/kg treatment microfilaria rates had persisted at low levels. Following systematic social mobilisation the first MDA with DEC albendazole combination was conducted in 2002.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We investigated the extent social mobilisation had reached the people, their drug compliance and adverse reactions. Three localities were selected from each district to pick target population samples for pre-tested questionnaire. Three teams each with six people visited one district each day. One team worked from three starting points in one locality. A member applied eight part questionnaire to one family member totalling 150\u2013160 people from one locality. Questions included social mobilisation, drug compliance and adverse reactions.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Information was disseminated by television, radio, banners and leaflets, to a lesser extent by people. Information reached more people in the periphery than in Colombo. 35.2% from Colombo municipality were unaware of the MDA. Drug coverage was 79.6%, home delivery 71.7% and delivery centres 7.9%. 35.6% in Colombo district and 53.4% from Colombo municipality did not receive drugs. Drugs were consumed by 71.4%. 28.6% who did not comply included 20.4% who did not receive them. 91.4% showed no adverse reactions, 7.5% were mild, 1.1% recovered with home remedies.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Drug compliance showed significant positive correlation with awareness of the MDA. Door to door delivery was more successful than delivery from centres. More delivery centres conveniently located would have rectified this disparity. Poor awareness and compliance in Colombo and urban areas could be rectified with separate strategy for urban areas. More time for MDA and trained adequate manpower would ensure coverage to achieve elimination.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1475-2883-6-11","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T19:13:32Z","timestamp":1195154012000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka"],"prefix":"10.1186","volume":"6","author":[{"given":"Mirani V","family":"Weerasooriya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Channa T","family":"Yahathugoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshana","family":"Wickramasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kithsiri N","family":"Gunawardena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan A","family":"Dharmadasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchana K","family":"Vidanapathirana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman H","family":"Weerasekara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfred A","family":"Samarawickrema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,15]]},"reference":[{"key":"72_CR1","unstructured":"Liyanage TS: National Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. Unpublished Report to World Health Organisation"},{"key":"72_CR2","first-page":"1","volume":"542","author":"World Health Organization Expert Committee on Filariasis","year":"1974","unstructured":"World Health Organization Expert Committee on Filariasis: Third Report 1974 WHO Technical Report Series. Geneva. 1974, 542: 1-54.","journal-title":"Third Report 1974 WHO Technical Report Series. Geneva"},{"key":"72_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1365-3156.2000.00620.x","volume":"5","author":"EA Ottesen","year":"2000","unstructured":"Ottesen EA: The Global Programme to Eliminate Lymphatic Filariasis. Trop Med Int Health. 2000, 5: 591-594. 10.1046\/j.1365-3156.2000.00620.x.","journal-title":"Trop Med Int Health"},{"key":"72_CR4","first-page":"112","volume-title":"Basic Lymphoedema Management: Treatment and prevention of problems associated with lymphatic filariasis","author":"G Dreyer","year":"2002","unstructured":"Dreyer G, Addiss D, Deyer P, Noroes J: Basic Lymphoedema Management: Treatment and prevention of problems associated with lymphatic filariasis. 2002, New Hampshire: Hollis, 112-1","edition":"1"},{"key":"72_CR5","first-page":"491","volume":"75","author":"EA Ottsen","year":"1997","unstructured":"Ottsen EA, Duke BO, Karam M, Behbehani K: Strategies and tools for the Control\/elimination of lymphatic filariasis. Bull World Health Organ. 1997, 75: 491-503.","journal-title":"Bull World Health Organ"},{"key":"72_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1142\/9781848160866_0008","volume-title":"Lymphatic Filariasis","author":"EA Ottesen","year":"2000","unstructured":"Ottesen EA: Towards eliminating lymphatic filariasis. Lymphatic Filariasis. Edited by: Nutman TB. 2000, London: Imperial CollegePress, 201-215. [Pasvol G, Hoffman SL (Series Editors): Tropical Medicine Science and Practice, vol 1.]"},{"key":"72_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2883-2-13","volume":"2","author":"DH Molyneux","year":"2003","unstructured":"Molyneux DH: Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity. Filaria J. 2003, 2: 1-6. 10.1186\/1475-2883-2-13.","journal-title":"Filaria J"},{"key":"72_CR8","volume-title":"Unpublished Report","author":"TS Liyanage","year":"2002","unstructured":"Liyanage TS: National Plan for the Elimination of Lymphatic Filariasis, Anti-Filariasis Campaign, Ministry of Health Sri Lanka. Unpublished Report. 2002, Sri Lanka"},{"key":"72_CR9","volume-title":"WHO\/CDS\/CPE\/CEEE\/2000.15","author":"World Health Organization","year":"2000","unstructured":"World Health Organization: Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis. WHO\/CDS\/CPE\/CEEE\/2000.15. 2000, WHO, Geneva"},{"key":"72_CR10","volume-title":"Report prepared by Ministry of Health and World Health Organization, Geneva","author":"Anon","year":"2002","unstructured":"Anon: Communication\u2013for\u2013Behavioural Impact (COMBI) Plan for Lymphatic Filariasis Prevention in Sri Lanka. Report prepared by Ministry of Health and World Health Organization, Geneva. 2002"},{"key":"72_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4038\/cmj.v48i3.3343","volume":"48","author":"TC Yahathugoda","year":"2003","unstructured":"Yahathugoda TC, Wickramasinghe D, Liyanage TS, Weerasooriya MV, Mudalige MPS, Waidyaratna EI, Samarawickrema WA: Knowledge on Lymphaic Filariasis and the evaluation of the July 2002 Mass Treatment Programme in two communities in the Galle District. Ceylon Med J. 2003, 48: 74-77.","journal-title":"Ceylon Med J"},{"key":"72_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4038\/cmj.v46i4.6431","volume":"46","author":"KTAA Kasthriratna","year":"2001","unstructured":"Kasthriratna KTAA, Premaratna BAHR, Pathmeswaran A, de Silva NR, de Silva HJ: Compliance with mass chemotherapy programme for lymphatic filariasis. Ceylon Med J. 2001, 46: 126-129.","journal-title":"Ceylon Med J"},{"key":"72_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1179\/000349804X3135","volume":"98","author":"E Mathieu","year":"2004","unstructured":"Mathieu E, Lammie PJ, Radday J, Breach MJ, Streit T, Wendt J, Addiss DG: Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti. Ann Trop Med Parasitol. 2004, 98: 703-714. 10.1179\/000349804X3135.","journal-title":"Ann Trop Med Parasitol"},{"key":"72_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.pt.2006.05.010","volume":"22","author":"KA Mohammed","year":"2006","unstructured":"Mohammed KA, Molyneux DH, Albonico M, Rio F: Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme. Trends Parasitol. 2006, 22: 340-344. 10.1016\/j.pt.2006.05.010.","journal-title":"Trends Parasitol"},{"key":"72_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","volume":"9","author":"BV Babu","year":"2004","unstructured":"Babu BV, Kar SK: Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic Filariasis in Orissa, India. Trop Med Int Health. 2004, 9: 702-709. 10.1111\/j.1365-3156.2004.01247.x.","journal-title":"Trop Med Int Health"},{"key":"72_CR16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1365-3156.2000.00659.x","volume":"5","author":"KD Ramaiah","year":"2000","unstructured":"Ramaiah KD, Das PK, Appavoo NC, Ramu KC, Augustin DJ, Vijay Kumar KN, Chandrakala AV: A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single\u2013dose DEC mass treatment and some related operational aspects. Trop Med Int Health. 2000, 5: 842-847. 10.1046\/j.1365-3156.2000.00659.x.","journal-title":"Trop Med Int Health"},{"key":"72_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1046\/j.1365-3156.2001.00813.x","volume":"6","author":"KD Ramaiah","year":"2001","unstructured":"Ramaiah KD, Vijay Kumar KN, Chandrakala AV, Augusin DJ, Appavoo NC, Das PK: Effectiveness of community and health services-organised drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health. 2001, 6: 1062-1069. 10.1046\/j.1365-3156.2001.00813.x.","journal-title":"Trop Med Int Health"},{"key":"72_CR18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","volume":"68","author":"SI McLaughlin","year":"2003","unstructured":"McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, Lammie PJ, Lammie J, Rheingans R, Lafontant J: Frequency, severity, and costs of adverse reactions following mass treatment for Lymphatic Filariasis using diethylcarbamazine and albendazole in Leogane, Haiti. Am J Trop Med Hyg. 2003, 68: 568-573.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Filaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2883-6-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1475-2883-6-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2883-6-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:24:12Z","timestamp":1728383052000},"score":1,"resource":{"primary":{"URL":"https:\/\/filariajournal.biomedcentral.com\/articles\/10.1186\/1475-2883-6-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2007,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1186\/1475-2883-6-11","relation":{},"ISSN":["1475-2883"],"issn-type":[{"type":"electronic","value":"1475-2883"}],"subject":[],"published":{"date-parts":[[2007,11,15]]},"assertion":[{"value":"14 September 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}